<i>abo8</i> mutation decreases the activity of the root meristem. by Li Yang (6520)

Ammonium decreases apparent root meristem size and the number of dividing cells. by Ying Liu (18461)

TREM1 inhibition decreases HIV mediated inflammatory cytokine production. by Jinhee Hyun (6900683)

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. by Rozita Mohd (7411322)

Settling time for changes in the median of the Folded Normal distribution. by Ariel Burman (20329776)

CCS1477 decreases phosphorylated ATR (pATR) and phosphorylated ATM (pATM). by Changkun Hu (12077989)

Combining metformin and esomeprazole additively decreases sFlt-1 secretion and expression, and increases VEGF expression in placental and endothelial cells. by Tu’uhevaha J. Kaitu’u-Lino (317587)

Silencing of RCC1L isoforms alter the levels of mitochondrial ribosomal proteins and biogenesis factors resulting in decreased mitochondrial translation. by Aurelio Reyes (412135)

Inactivation of one allele of FT5. by Sophia Bigot (16469992)

Clinical characteristics of patients in the increased-, stable-, and decreased-RPR groups. by Kazuhiko Ikeuchi (9234268)

Subjects:

IL-1Ra treatment decreases activity and increases rest time in <i>mdx</i> mice. by Margaret E. Benny Klimek (2805361)

Four-fold decrease in [H⁺]_e shifted GLT-1a E_rev by −18 mV at both low and high glutamate concentrations. by Anatoli Y. Kabakov (729047)

Four-fold decrease in [K⁺]_e shifted GLT-1a E_rev by +22 mV at both low and high glutamate concentrations. by Anatoli Y. Kabakov (729047)

Fig 7 - by Henning Carstens (13132801)

Spontaneous oxycodone withdrawal initially flattens NREM power rhythms, decreases low frequency and increases high frequency power. by Michael Gulledge (20577135)

Mean absolute SHAP values of the most important predictors for APM_MN in each of the five folds of the first repeat. by Shubhayu Bhattacharyay (11242977)

BH3 Peptides induces a decrease in mitochondrial membrane potential but does not engage the Permeability Transition Pore. by Emelyn H. Shroff (163459)

Compounds decrease polyQ toxicity in a <i>pqe-1</i> independent manner in aged animals. by Cindy Voisine (30589)

Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity. by Nevena Grdović (394542)

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC₅₀ concentration of fenretinide during different time points (24–48–72 hours). …”